Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTR6 | P50406 | 2/20 | 0.41 |
| ▸ | IDO1 | P14902 | 2/20 | 0.41 |
| ▸ | PDPK1 | O15530 | 1/20 | 0.41 |
| ▸ | CA1 | P00915 | 1/20 | 0.39 |
| ▸ | CA2 | P00918 | 1/20 | 0.39 |
| ▸ | CYP11B2 | P19099 | 1/20 | 0.39 |
| ▸ | PIN1 | Q13526 | 1/20 | 0.37 |
| ▸ | ACP3 | P15309 | 1/20 | 0.37 |
| ▸ | SRD5A1 | P18405 | 2/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9845721 | 0.79 | IDO1 (0.44) | HTR6IDO1PDPK1CA1CA2 | |
| SCHEMBL27668901 | 0.79 | IDO1 (0.41) | HTR6IDO1PDPK1CA1CA2 | |
| SCHEMBL27868055 | 0.79 | DRD2 (0.46) | IDO1PDPK1CA1CA2CYP11B2 | |
| SCHEMBL14240894 | 0.79 | BLM (0.47) | HTR6IDO1PDPK1CA1CA2 | |
| Hydrochloric Acid SCHEMBL28648863 | 0.77 | IDO1 (0.46) | HTR6IDO1PDPK1CA1CA2 | |
| SCHEMBL10181685 | 0.77 | IDO1 (0.48) | HTR6IDO1PDPK1CA1CA2 | |
| SCHEMBL790430 | 0.77 | IDO1 (0.48) | HTR6IDO1PDPK1CA1CA2 | |
| SCHEMBL28745539 | 0.76 | SIGMAR1 (0.54) | IDO1PDPK1CA1CA2CYP11B2 | |
| SCHEMBL9165650 | 0.73 | IDO1 (0.46) | HTR6IDO1PDPK1CA1CA2 | |
| SCHEMBL21937667 | 0.73 | IDO1 (0.46) | HTR6IDO1PDPK1CA1CA2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20150010504-A1 | Antiviral Compounds with a Heterotricycle Moiety | LUPIN LIMITED (IN) | 2015-01-08 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150010504-A1 | Antiviral Compounds with a Heterotricycle Moiety | HCCS, UQCRB, HAVCR2 | HTR6 3456/4885IDO1 2532/4885PDPK1 3066/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.